文献速递临床血液与体液质量管理与危急值

温度对新生儿镰状细胞病筛查干血斑血红蛋白稳定性的影响

Impact of temperature on hemoglobin stability in dried blood spots for newborn screening for sickle cell disease.
PubMed 文献 · Clin Chim Acta · 2026-10-15

该研究评估了干血斑样本在+4°C、+37°C和+42°C下储存30天内血红蛋白组分(HbF、HbA0、HbS、HbFast和乙酰化HbF)的稳定性,采用阳离子交换高效液相色谱分析。结果显示储存温度是血红蛋白稳定性的主要决定因素,+4°C下多数组分无显著时间趋势,而+37°C和+42°C下部分组分变化显著且稳定性时限明显缩短。

要点

  • 干血斑血红蛋白稳定性呈温度依赖性,+4°C下30天内多数组分稳定。
  • 高温下HbFast稳定性时限最短,HbA0和HbF居中,低HbS水平样本中HbS稳定性更差。
  • 基于回归的EFLM框架可定量评估稳定性,支持制定操作储存时限。

核心结论

  • 干血斑中血红蛋白稳定性强烈依赖温度,并呈现分析物特异性降解模式。

研究设计与样本

  • 评估干血斑样本在+4°C、+37°C和+42°C储存长达30天的血红蛋白组分稳定性,采用阳离子交换高效液相色谱分析脐带血及掺入约5%或约15% HbS的样本。

主要发现

  • 储存温度是血红蛋白稳定性的主要决定因素;+4°C下多数组分30天内无显著时间趋势。
  • +37°C和+42°C下若干组分出现统计学显著变化,日变化率增加且稳定性时限明显缩短。
  • HbFast在高温下稳定性时限最短,HbA0和HbF呈中等稳定性,HbS在较高温度下稳定性降低且低HbS水平样本中更明显。

关键数值与推荐

  • 采用基于回归的EFLM推荐方法评估稳定性,估计时间趋势、日变化率和稳定性时限。
  • 稳定性分类和估计的稳定性时限随温度升高一致变差。

临床怎么用

  • 研究结果为优化干血斑储存和运输条件提供循证指导,支持资源有限地区实施可扩展的镰状细胞病筛查项目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sickle cell disease (SCD) is a major genetic disorder with a growing global burden, particularly in sub-Saharan Africa. Newborn screening based on dried blood spot (DBS) samples is an effective strategy for early diagnosis; however, prolonged transport times and exposure to high temperatures may compromise analytical reliability in resource-limited settings. METHODS: We evaluated the stability of hemoglobin fractions (HbF, HbA0, HbS, HbFast, and acetylated HbF) in DBS samples stored at +4 °C, +37 °C, and + 42 °C for up to 30 days. Native cord blood samples and samples spiked with HbS (~5% or ~ 15%) were analysed by cation-exchange high-performance liquid chromatography (CX-HPLC; VARIANT® NBS system). Stability was assessed using a regression-based approach in accordance with European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) recommendations, estimating time-dependent trends, daily rates of change, and stability limits. RESULTS: Storage temperature was the main determinant of hemoglobin stability. At +4 °C, most hemoglobin fractions showed no significant time-dependent trends over 30 days. At +37 °C and + 42 °C, several fractions exhibited statistically significant changes, with increasing daily variation rates and markedly reduced stability limits. HbFast showed the shortest stability limits at elevated temperatures, while HbA0 and HbF displayed intermediate stability profiles. HbS showed reduced stability at higher temperatures, with borderline or unstable classifications and short stability limits, particularly in samples with lower HbS levels. Overall, stability classifications and estimated stability limits consistently worsened with increasing temperature. CONCLUSIONS: Hemoglobin stability in DBS samples is strongly temperature-dependent and follows analyte-specific degradation patterns. The application of a regression-based EFLM framework enables a quantitative and reproducible assessment of stability and supports the definition of operational storage limits. These findings provide evidence-based guidance for optimizing DBS storage and transport conditions and support the implementation of scalable SCD screening programs in resource-limited settings.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Rolla R, Vidali M, Giacomini L, et al. Impact of temperature on hemoglobin stability in dried blood spots for newborn screening for sickle cell disease. Clin Chim Acta. 2026. PMID: 42880434. doi:10.1016/j.cca.2026.122909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。